As of 3:59pm ET
| -0.039 / -4.59%|
The 1 analysts offering 12-month price forecasts for MabVax Therapeutics Holdings Inc have a median target of 18.00, with a high estimate of 18.00 and a low estimate of 18.00. The median estimate represents a +2,122.22% increase from the last price of 0.81.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.